ZACKS INVESTMENT MANAGEMENT - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ZACKS INVESTMENT MANAGEMENT ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$347,000
-8.4%
53,963
-3.5%
0.01%
-25.0%
Q3 2020$379,000
-46.5%
55,931
-26.5%
0.01%
-50.0%
Q2 2020$709,00076,1140.02%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 12,202,510$10,6161.33%
Tri Locum Partners LP 3,878,484$3,374,2811.03%
Lynwood Capital Management Inc. 900,000$783,0000.71%
NEA Management Company, LLC 11,736,793$10,211,0100.71%
Parkman Healthcare Partners LLC 2,797,147$2,433,5180.53%
SCOGGIN MANAGEMENT LP 484,796$567,0250.33%
New Leaf Venture Partners, L.L.C. 335,000$291,4500.24%
Ghost Tree Capital, LLC 850,000$740,0000.22%
Perceptive Advisors 4,545,454$3,954,5450.12%
Orbimed Advisors 5,817,726$5,061,4220.10%
View complete list of X4 PHARMACEUTICALS INC shareholders